You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

multikinase inhibitor

Showing 1 - 25 of 7,404
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Metastatic Pancreatic Adenocarcinoma Trial in Cleveland (Regorafenib, Gemcitabine Hydrochloride)

Terminated
Has Results
  • Metastatic Pancreatic Adenocarcinoma
  • Cleveland, Ohio
    Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Ca
Jun 1, 2022

Hepatocellular Carcinoma Non-resectable Trial in Guangzhou (TACE combined with sorafenib/lenvatinib and iodion-125 seeds

Recruiting
  • Hepatocellular Carcinoma Non-resectable
  • TACE combined with sorafenib/lenvatinib and iodion-125 seeds brachytherapy
  • TACE combined with sorafenib/lenvatinib
  • Guangzhou, Guangdong, China
    the Second Affiliated Hospital of Guangzhou Medical University
Jul 27, 2021

Adult Angiosarcoma, Recurrent Adult Soft Tissue Sarcoma, Stage III Adult Soft Tissue Sarcoma Trial in United States

Completed
Has Results
  • Adult Angiosarcoma
  • +3 more
  • Santa Monica, California
  • +6 more
Mar 29, 2022

Gastrinoma, Glucagonoma, Insulinoma Trial in United States (regorafenib, laboratory biomarker analysis)

Completed
Has Results
  • Gastrinoma
  • +8 more
  • Scottsdale, Arizona
  • +4 more
Nov 15, 2021

Renal Cell Carcinoma, Urothelial Carcinoma, Cervical Cancer Trial in Shanghai (SHR-1210, Famitinib)

Recruiting
  • Renal Cell Carcinoma
  • +4 more
  • Shanghai, Shanghai, China
    Huadong Hospital Affiliated to Fudan University
Jun 30, 2022

Liver Transplant; Complications, Hepatocarcinoma, Recurrent Osteosarcoma Trial in Beijing (multi-kinase inhibitors in

Not yet recruiting
  • Liver Transplant; Complications
  • +3 more
  • multi-kinase inhibitors in combination with bevacizumab
  • Beijing, Beijing, China
    Chinese Academy of Medical Sciences & Peking Union Medical Colle
Sep 11, 2023

Acute Myeloid Leukemia (AML) Trial in Tianjin (Donafenib)

Recruiting
  • Acute Myeloid Leukemia (AML)
  • Tianjin, Tianjin, China
    Institute of Hematology and Blood Disease Hospital
Jun 21, 2021

Child Solid Tumor Trial in United Kingdom (multikinase inhibitor AT9283, enzyme-linked immunosorbent assay, immunohistochemistry

Completed
  • Unspecified Childhood Solid Tumor, Protocol Specific
  • multikinase inhibitor AT9283
  • +4 more
  • Birmingham, England, United Kingdom
  • +4 more
Nov 27, 2019

Response in Patients Treated by Immunotherapy for Advanced

Not yet recruiting
  • Hepatocellular Carcinoma
  • patients with hepatocellular carcinoma
  • (no location specified)
Jan 28, 2022

Differentiated Thyroid Cancer Which is Radioactive Iodine

Completed
  • Thyroid Neoplasms
  • Sorafenib (Nexavar, BAY43-9006)
  • Other Multikinase inhibitors
  • Birmingham, Alabama
  • +33 more
Jun 6, 2021

Acute Leukemia, Relapse, Hematopoietic Stem Cell Transplantation Trial in Guangzhou (Sorafenib)

Recruiting
  • Acute Leukemia
  • +2 more
  • Guangzhou, Guangdong, China
    Department of Hematology,Nanfang Hospital, Southern Medical Univ
Oct 30, 2021

Hepatocellular Carcinoma Trial in Taichung (Xiang Sha Liu Jun Zi Decoction dry powder, XSLJZ Placebo)

Enrolling by invitation
  • Hepatocellular Carcinoma
  • Xiang Sha Liu Jun Zi Decoction dry powder
  • XSLJZ Placebo
  • Taichung, 西屯區, Taiwan
    China Medical University hospital
Dec 9, 2021

Pancreas Cancer, Ovarian Cancer, Melanoma Trial in Rozzano (Regorafenib)

Completed
  • Pancreas Cancer
  • +6 more
  • Rozzano, Milan, Italy
    Istituto Clinico Humanitas
Sep 9, 2022

Cancer Trial in Heidelberg, Mainz (combination of Avelumab and Cabozantinib)

Recruiting
  • Cancer
  • combination of Avelumab and Cabozantinib
  • Heidelberg, Germany
  • +1 more
Mar 31, 2022

Hepatocellular Carcinoma Trial in Seoul (Lenvatinib)

Recruiting
  • Hepatocellular Carcinoma
  • Seoul, Korea, Republic of
    Asan Medical Center
Nov 14, 2023

Metastatic Thyroid Gland Carcinoma, Poorly Differentiated Thyroid Gland Carcinoma, Thyroid Gland Anaplastic Carcinoma by AJCC V8

Suspended
  • Metastatic Thyroid Gland Carcinoma
  • +2 more
  • Saint Petersburg, Russian Federation
    Saint-Petersburg State University (SPSU) N.I.Pirogov Clinic of H
May 13, 2021

Medullary Thyroid Cancer Trial in Cordoba, Sevilla (Pralsetinib, Cabozantinib, Vandetanib)

Not yet recruiting
  • Medullary Thyroid Cancer
  • Cordoba, Spain
  • +1 more
Jan 11, 2023

Hepatocellular Carcinoma Trial in Dhaka (Lenvatinib)

Recruiting
  • Hepatocellular Carcinoma
  • Dhaka, Bangladesh
  • +1 more
May 21, 2022

Melanoma Trial in Seoul (regorafenib)

Recruiting
  • Melanoma
  • Seoul, Korea, Republic of
    Severance Hospital, Yonsei University Health System
Apr 1, 2021

Type B3 Thymoma, Thymic Carcinoma Trial in Milan (Sunitinib)

Recruiting
  • Type B3 Thymoma
  • Thymic Carcinoma
  • Milan, Italy
    National Cancer Institute
Jun 8, 2021

Advanced Cancer Trial in La Jolla (Lucitanib)

Withdrawn
  • Advanced Cancer
  • La Jolla, California
    UC San Diego Moores Cancer Center
Jul 31, 2018

Digestive Cancer, Metastatic Colorectal Cancer, Hepatocellular Carcinoma Trial in France (Blood sampling to build population

Recruiting
  • Digestive Cancer
  • +4 more
  • Blood sampling to build population pharmacokinetics model
  • Auxerre, France
  • +23 more
Aug 30, 2022

Germ Cell Tumors, Measurable Disease Trial in Milano (Pazopanib)

Completed
  • Germ Cell Tumors
  • Measurable Disease
  • Milano, Mi, Italy
    Fondazione IRCCS Istituto Nazionale dei Tumori
May 12, 2021

Angiogenesis Polymorphisms In HCC Patients Treated With

Unknown status
  • Hepatocellular Carcinoma
  • blood sample collection
  • Bari, BA, Italy
  • +9 more
Feb 25, 2021

Advanced Hepatocellular Carcinoma, HCC, Liver Cancer Trial in Philadelphia (PD-0332991)

Active, not recruiting
Has Results
  • Advanced Hepatocellular Carcinoma
  • +2 more
  • Philadelphia, Pennsylvania
    Thomas Jefferson University
Sep 21, 2021